Oncotarget

Research Papers:

TGFβ1 and TNFα synergistically induce epithelial to mesenchymal transition of breast cancer cells by enhancing TAK1 activation

PDF  |  Full Text  |  How to cite

DOI pending

Sheng-Jun Liao1,2, Jing Luo2, Dong Li2, Yuan-Hong Zhou2, Bin Yan2, Jing-Jing Wei2, Jian-Cheng Tu1, Yi-Rong Li1, Gui-Mei Zhang2 and Zuo-Hua Feng2

1Department of Clinical Laboratory, Zhongnan Hospital of Wuhan University, Wuhan, 430071, Hubei, China

2Department of Biochemistry and Molecular Biology, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, 430030, Hubei, China

Correspondence to:

Sheng-Jun Liao, email: [email protected]

Zuo-Hua Feng, email: [email protected]

Keywords: TGF-β1; TNF-α; epithelial to mesenchymal transition; breast cancer; invasion

Received: June 21, 2017    Accepted: February 26, 2018    Published:

ABSTRACT

TGF-β1 is a main inducer of epithelial to mesenchymal transition (EMT). However, many breast cancer cells are not sensitive to the EMT induction by TGF-β1 alone. So far, the mechanisms underlying the induction of TGF-β1-insensitive breast cancer cells remains unclear. Here we report that TNF-α can induce EMT and invasiveness of breast cancer cells which are insensitive to TGF-β1. Intriguingly, TGF-β1 could cooperate with TNF-α to promote the EMT and invasiveness of breast cancer cells. The prolonged co-stimulation with TGF-β1 and TNF-α could enhance the sustained activation of Smad2/3, p38 MAPK, ERK, JNK and NF-κB pathways by enhancing the activation of TAK1, which was mediated by the gradually up-regulated TβRs. Except for JNK, all of these pathways were required for the effects of TGF-β1 and TNF-α. Importantly, the activation of p38 MAPK and ERK pathways resulted in a positive feed-back effect on TAK1 activation by up-regulating the expression of TβRs, favoring the activation of multiple signaling pathways. Moreover, SLUG was up-regulated and required for the TGF-β1/TNF-α-induced EMT and invasiveness. In addition, SLUG could also enhance the activation of singling pathways by promoting TβRII expression. These findings suggest that the up-regulation of TβRs contributes to the sustained activation of TAK1 induced by TGF-β1/TNF-α and the following activation of multiple signaling pathways, resulting in EMT and invasiveness of breast cancer cells.